|
Compilation of clinical data of the breast cancer patients used in the study. |
|||
| 10-year survivors |
deceased |
Total |
|
|
|
|||
| Mean age |
48 |
53 |
50 |
| Surgery |
|||
| breast preserving |
11 |
11 |
22 |
| mastectomy |
12 |
12 |
24 |
| total |
23 |
23 |
46 |
| Histology |
|||
| ductal |
19 |
14 |
33 |
| lobular |
1 |
2 |
3 |
| mucinous |
2 |
0 |
2 |
| medullary |
0 |
1 |
1 |
| tubular |
0 |
1 |
1 |
| comedocarcinoma |
0 |
1 |
1 |
| adenocarcinoma |
0 |
1 |
1 |
| not available |
1 |
3 |
4 |
| total |
23 |
23 |
46 |
| Receptor Status |
|||
| estrogen positive |
12 |
11 |
23 |
| progesterone positive |
11 |
5 |
16 |
| unavailable |
1 |
0 |
1 |
| Ploidi |
|||
| diploid |
7 |
3 |
10 |
| aneuploid |
13 |
13 |
26 |
| polyploid |
2 |
2 |
4 |
| not available |
1 |
5 |
6 |
| total |
23 |
23 |
46 |
| S-phase |
|||
| < 12% |
14 |
7 |
21 |
| >= 12% |
3 |
8 |
11 |
| not available |
6 |
8 |
14 |
| total |
23 |
23 |
46 |
Karlsson et al. BMC Cancer 2008 8:254 doi:10.1186/1471-2407-8-254 |
|||